呼吸系统疾病国家临床医学研究中心

发布年份:
论文篇名 期刊名称 影响因子 发布年份
  • SARS-CoV-2 immunity in animal models CELLULAR & MOLECULAR IMMUNOLOGY 21.80 2024
  • Comments on Swedish Study of Pregnancy Outcomes and Maternal Mortality JAMA INTERNAL MEDICINE 22.50 2024
  • Electrical impedance tomography-guided positive end-expiratory pressure titration in ARDS: a systematic review and meta-analysis INTENSIVE CARE MEDICINE 27.10 2024
  • ACE2 Receptor-Targeted Inhaled Nanoemulsions Inhibit SARS-CoV-2 and Attenuate Inflammatory Responses ADVANCED MATERIALS 27.40 2024
  • The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis NATURE IMMUNOLOGY 27.70 2024
  • Concurrent intratumoural Treg cell depletion and CD8+ T cell expansion via a cleavable anti-4-1BB-interleukin-15 fusion protein NATURE BIOMEDICAL ENGINEERING 27.70 2024
  • The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments MOLECULAR CANCER 27.70 2024
  • Global cancer statistics for adolescents and young adults: population based study JOURNAL OF HEMATOLOGY & ONCOLOGY 29.90 2024
  • Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension CIRCULATION 35.60 2024
  • Safety and efficacy of onradivir in adults with acute uncomplicated influenza A infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial LANCET INFECTIOUS DISEASES 36.40 2024
  • Optimising vaccine immunogenicity in ageing populations: key strategies LANCET INFECTIOUS DISEASES 36.40 2024
  • The activity and immune dynamics of PD-1 inhibition on high-risk pulmonary ground glass opacity lesions: insights from a single-arm, phase II trial SIGNAL TRANSDUCTION AND TARGETED THERAPY 40.80 2024